Health Care & Life Sciences » Biotechnology | Vanc Pharmaceuticals Inc.

Vanc Pharmaceuticals Inc. | Income Statement

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
-
-
5.70
1,013.70
537.70
Cost of Goods Sold (COGS) incl. D&A
-
0.90
71.10
725.60
304.70
Gross Income
-
0.90
65.30
288.10
233.00
SG&A Expense
193.10
770.30
1,662.00
2,623.50
2,252.50
EBIT
193.10
771.20
1,727.40
2,627.20
2,765.40
Unusual Expense
475.00
40.70
476.00
-
-
Non Operating Income/Expense
1.50
0.80
3.70
6.20
31.50
Interest Expense
-
2.60
1.10
1.30
2.70
Pretax Income
283.40
733.90
2,200.60
2,613.90
2,736.70
Consolidated Net Income
283.40
733.90
2,200.60
2,613.90
2,736.70
Net Income
283.40
733.90
2,200.60
2,613.90
2,736.70
Net Income After Extraordinaries
283.40
733.90
2,200.60
2,613.90
2,736.70
Net Income Available to Common
283.40
733.90
2,200.60
2,613.90
2,736.70
EPS (Basic)
0.08
0.12
0.20
0.18
0.15
Basic Shares Outstanding
4,705.30
6,526.90
11,818.20
14,907.10
18,393.20
EPS (Diluted)
0.06
0.11
0.19
0.18
0.15
Diluted Shares Outstanding
4,705.30
6,526.90
11,818.20
14,907.10
18,393.20
EBITDA
193.10
770.30
1,713.50
2,612.50
2,751.60
Other Operating Expense
-
-
-
291.80
746.00
Non-Operating Interest Income
-
-
0.10
8.50
-

About Vanc Pharmaceuticals

View Profile
Address
789 West Pender Street
Vancouver British Columbia V6C 1H2
Canada
Employees -
Website http://www.vancpharm.com
Updated 09/14/2018
Vanc Pharmaceuticals, Inc. engages in the manufacture and sale of over-the-counter healthcare products. Its products include Hema-fer, Cortivera and Sennace. The company was founded on May 30, 2000 and is headquartered in Vancouver, Canada.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.